Hohimer Wealth Management LLC Invests $4.15 Million in Cigna Group $CI

Hohimer Wealth Management LLC acquired a new stake in shares of Cigna Group (NYSE:CIFree Report) during the third quarter, Holdings Channel.com reports. The fund acquired 14,382 shares of the health services provider’s stock, valued at approximately $4,146,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Cigna Group by 3.2% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 531,898 shares of the health services provider’s stock valued at $153,320,000 after buying an additional 16,496 shares during the period. AlphaCore Capital LLC increased its stake in shares of Cigna Group by 31.5% in the third quarter. AlphaCore Capital LLC now owns 2,574 shares of the health services provider’s stock worth $742,000 after acquiring an additional 616 shares during the last quarter. Intech Investment Management LLC raised its holdings in shares of Cigna Group by 242.6% during the third quarter. Intech Investment Management LLC now owns 72,724 shares of the health services provider’s stock worth $20,963,000 after acquiring an additional 51,496 shares in the last quarter. MAI Capital Management boosted its position in Cigna Group by 52.5% during the third quarter. MAI Capital Management now owns 14,124 shares of the health services provider’s stock valued at $4,071,000 after purchasing an additional 4,860 shares during the last quarter. Finally, RWA Wealth Partners LLC grew its stake in Cigna Group by 816.2% in the third quarter. RWA Wealth Partners LLC now owns 22,666 shares of the health services provider’s stock valued at $6,534,000 after purchasing an additional 20,192 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 1.7%

Shares of Cigna Group stock opened at $289.14 on Friday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a quick ratio of 0.76, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average price of $279.63 and a two-hundred day moving average price of $284.45. The stock has a market capitalization of $77.24 billion, a P/E ratio of 13.04, a PEG ratio of 0.99 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the firm posted $6.64 earnings per share. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CI. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a research report on Tuesday, January 6th. Wells Fargo & Company dropped their price objective on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Finally, Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $330.63.

View Our Latest Analysis on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.